MXPA03007268A - Metodo de uso antiviral. - Google Patents

Metodo de uso antiviral.

Info

Publication number
MXPA03007268A
MXPA03007268A MXPA03007268A MXPA03007268A MXPA03007268A MX PA03007268 A MXPA03007268 A MX PA03007268A MX PA03007268 A MXPA03007268 A MX PA03007268A MX PA03007268 A MXPA03007268 A MX PA03007268A MX PA03007268 A MXPA03007268 A MX PA03007268A
Authority
MX
Mexico
Prior art keywords
antiviral method
antiviral
Prior art date
Application number
MXPA03007268A
Other languages
English (en)
Inventor
Douglas Wayne Balogh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MXPA03007268A publication Critical patent/MXPA03007268A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
MXPA03007268A 2001-02-16 2002-02-04 Metodo de uso antiviral. MXPA03007268A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26948601P 2001-02-16 2001-02-16
US29329701P 2001-05-24 2001-05-24
PCT/US2002/001233 WO2002066037A2 (en) 2001-02-16 2002-02-04 Antiviral method of use

Publications (1)

Publication Number Publication Date
MXPA03007268A true MXPA03007268A (es) 2003-12-04

Family

ID=26953723

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007268A MXPA03007268A (es) 2001-02-16 2002-02-04 Metodo de uso antiviral.

Country Status (8)

Country Link
US (1) US20040067965A1 (es)
EP (1) EP1377296A2 (es)
JP (1) JP2004529880A (es)
CN (1) CN1491111A (es)
BR (1) BR0207124A (es)
CA (1) CA2432929A1 (es)
MX (1) MXPA03007268A (es)
WO (1) WO2002066037A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체

Also Published As

Publication number Publication date
EP1377296A2 (en) 2004-01-07
US20040067965A1 (en) 2004-04-08
BR0207124A (pt) 2004-06-22
WO2002066037A8 (en) 2003-12-24
CA2432929A1 (en) 2002-08-29
WO2002066037A2 (en) 2002-08-29
CN1491111A (zh) 2004-04-21
JP2004529880A (ja) 2004-09-30
WO2002066037A3 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
GB0109993D0 (en) Method
MXPA03007834A (es) Uso de agonistas inversos de gabaa, en combinacion con agonistas parciales del receptor de nicotina, estrogenos, moduladores selectivos de estrogenos o vitamina e, para el tratamiento de transtornos cognitivos.
GB0122049D0 (en) Method
GB0128438D0 (en) Method
HUP0400345A3 (en) Antiviral phosphono-pyrimidine derivatives
GB0109049D0 (en) Method
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
EP1375513A4 (en) IMMUNOSTIMULANTS
GB0126531D0 (en) Method
GB0114629D0 (en) Method
GB0110547D0 (en) Method
GB0108349D0 (en) Method
GB0101762D0 (en) Method
MXPA03007268A (es) Metodo de uso antiviral.
GB0106567D0 (en) Mutuagenesis Technique
GB0102947D0 (en) Method
GB0119339D0 (en) Method
GB0125793D0 (en) Method
GB0111987D0 (en) Method
GB0128629D0 (en) Method
GB0119269D0 (en) Method
GB0104031D0 (en) Antiviral treatment
GB0104030D0 (en) Antiviral treatment
GB0123549D0 (en) Processes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal